Frequent Loss in Chromosome 8p Loci in Liver Cirrhosis Accompanying Hepatocellular Carcinoma

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 1996 Jan 1

PMID 8879255

Citations 10

Authors

Y Kishimoto

G Shiota

K Wada

M Kitano

K Nakamoto

Y Kamisaki

T Suou

T Itoh

H Kawasaki

Affiliations

Soon will be listed here.

Abstract

Most hepatocellular carcinoma (HCC) is preceded by liver cirrhosis, but the genetic changes involved in cirrhosis are not well understood. We therefore studied loss of heterozygosity (LOH) in cirrhotic and neoplastic foci in livers of 14 patients with HCC. The samples, microdissected from paraffin-embedded tissues, were analyzed using a polymerase-chain-reaction-based assay for dinucleotide repeat polymorphisms on 8p. Of the 14 cases, 13 showed constitutional heterozygosity for the microsatellite markers. In 7 (54%) of these 13 informative cases, LOH was detected in the primary HCC and, in these 7 doubly informative (informative and LOH-positive in primary HCC) cases, LOH was found in 16 (70%) of 23 liver cirrhotic foci. The pattern of 8p allelic loss was identical in each doubly informative tumor; however, some of the liver cirrhotic foci harbored an 8p loss identical to that seen in the primary HCC, some harbored a different 8p loss, and some did not harbor any 8p loss. The remaining 6 cases without LOH on 8p in HCC showed no 8p loss in any cirrhotic foci. Presumably HCC could develop from cirrhotic cells harboring 8p loss.

Citing Articles

The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis.

Shahrisa A, Tahmasebi-Birgani M, Ansari H, Mohammadi Z, Carloni V, Mohammadi Asl J Mol Cytogenet. 2021; 14(1):33.

PMID: 34215297 PMC: 8254242. DOI: 10.1186/s13039-021-00553-2.

Prognostic and Clinicopathological Value of in Various Human Tumors: A Meta-Analysis.

Liang H, Xiong Z, Li Y, Kong W, Yao Z, Li R Biomed Res Int. 2018; 2018:4621015.

PMID: 30079348 PMC: 6069698. DOI: 10.1155/2018/4621015.

Association between the and polymorphisms and serum lipid levels.

Zhang Q, Yin R, Huang F, Yang D, Lin W, Pan S Oncotarget. 2018; 8(69):114081-114094.

PMID: 29371971 PMC: 5768388. DOI: 10.18632/oncotarget.23123.

PinX1: structure, regulation and its functions in cancer.

Li H, Song J, Yong H, Hou P, Chen Y, Song W Oncotarget. 2016; 7(40):66267-66275.

PMID: 27556185 PMC: 5323232. DOI: 10.18632/oncotarget.11411.

PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.

Li H, Han L, Chen H, Meng F, Liu Q, Pan Z Oncotarget. 2015; 6(25):21406-20.

PMID: 26033551 PMC: 4673274. DOI: 10.18632/oncotarget.4011.

References

Murakami Y, Hayashi K, Hirohashi S, Sekiya T . Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991; 51(20):5520-5. View

Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen N . p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 1992; 7(10):1989-97. View

Lerer I, Meiner V, Abeliovich D . Molecular diagnosis of Prader-Willi syndrome: parent-of-origin dependent methylation sites and non-isotopic detection of (CA)n dinucleotide repeat polymorphisms. Am J Med Genet. 1994; 52(1):79-84. DOI: 10.1002/ajmg.1320520116. View

Knowles M, Shaw M, Proctor A . Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene. 1993; 8(5):1357-64. View

Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K . Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer. 1992; 51(6):862-8. DOI: 10.1002/ijc.2910510605. View

Ishizu H . Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma. Jpn J Surg. 1989; 19(6):662-73. DOI: 10.1007/BF02471716. View

Macoska J, Trybus T, Benson P, Sakr W, Grignon D, Wojno K . Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res. 1995; 55(22):5390-5. View

Marshall C . Tumor suppressor genes. Cell. 1991; 64(2):313-26. DOI: 10.1016/0092-8674(91)90641-b. View

Miki Y, Nishisho I, Miyoshi Y, Utsunomiya J, Nakamura Y . Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient. Genes Chromosomes Cancer. 1992; 4(1):81-3. DOI: 10.1002/gcc.2870040112. View

10.

Walker G, Hayward N, Falvey S, Cooksley W . Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 1991; 51(16):4367-70. View

11.

Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M . Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 1990; 81(2):108-11. PMC: 5963891. DOI: 10.1111/j.1349-7006.1990.tb02534.x. View

12.

McEntee G, Batts K, Katzmann J, Ilstrup D, Nagorney D . Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery. 1992; 111(4):376-9. View

13.

OConnell P, Pekkel V, Fuqua S, Osborne C, Allred D . Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat. 1994; 32(1):5-12. DOI: 10.1007/BF00666201. View

14.

Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix J . Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene. 1995; 10(5):1023-6. View

15.

Iwao Y, Kim Y, Kaketani K, Nakashima K, Okada K, Kobayashi M . Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma. Hepatogastroenterology. 1993; 40(5):491-5. View

16.

Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M . Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene. 1995; 10(5):891-5. View

17.

Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y . Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 1993; 17(5):794-9. View

18.

Wistuba I, Sugio K, Hung J, Kishimoto Y, Virmani A, Roa I . Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995; 55(12):2511-5. View

19.

Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E . Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991; 51(1):89-93. View

20.

Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M . Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer. 1991; 67(4):939-44. DOI: 10.1002/1097-0142(19910215)67:4<939::aid-cncr2820670414>3.0.co;2-j. View